Roger Brüggemann

Radboud University Medical Center, Netherlands

Roger is associate professor in clinical pharmacology of anti-infectives.

He is responsible for the translational pharmacological research on antifungal drugs. His work involves three domains ranging from in vitro and animal research to trials in humans with strong national and international collaborations.

Roger’s research involves the pharmacological research in special patient populations (paediatrics, ICU, obese, patients with Viral Associated Fungal Infections) and PK-PD behaviour of (novel) antifungal drugs and factors that impact this.

He is board member of the Center of Expertise in Mycology Radboudumc/CWZ, fellow of the European Confederation of Medical Mycology and a member of numerous international societies. Roger has helped draft multiple international guidelines for management of patients with fungal disease.